Total Payments
$797.52
2024 Payments
$149.79
Companies
7
Transactions
45
Medicare Patients
710
Medicare Billing
$39,498
Payment Breakdown by Category
Food & Beverage$797.52 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $797.52 | 45 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $549.80 | 35 | $0 (2024) |
| GlaxoSmithKline, LLC. | $85.55 | 1 | $0 (2021) |
| Novo Nordisk Inc | $63.35 | 3 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $43.24 | 2 | $0 (2022) |
| PFIZER INC. | $28.70 | 2 | $0 (2022) |
| Lilly USA, LLC | $14.47 | 1 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $12.41 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $149.79 | 9 | ABBVIE INC. ($135.32) |
| 2023 | $271.87 | 15 | ABBVIE INC. ($232.41) |
| 2022 | $239.86 | 17 | ABBVIE INC. ($147.52) |
| 2021 | $136.00 | 4 | GlaxoSmithKline, LLC. ($85.55) |
All Payment Transactions
45 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.26 | General |
| Category: NEUROSCIENCE | ||||||
| 11/20/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.62 | General |
| Category: NEUROSCIENCE | ||||||
| 11/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.96 | General |
| Category: NEUROSCIENCE | ||||||
| 05/13/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.84 | General |
| Category: NEUROSCIENCE | ||||||
| 03/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $32.64 | General |
| Category: NEUROSCIENCE | ||||||
| 03/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.27 | General |
| Category: NEUROSCIENCE | ||||||
| 02/28/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.45 | General |
| Category: NEUROSCIENCE | ||||||
| 02/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: NEUROSCIENCE | ||||||
| 01/12/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $14.47 | General |
| Category: Obesity | ||||||
| 12/13/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $26.63 | General |
| Category: NEUROSCIENCE | ||||||
| 12/04/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.64 | General |
| Category: NEUROSCIENCE | ||||||
| 11/07/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.31 | General |
| Category: NEUROSCIENCE | ||||||
| 11/06/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.84 | General |
| Category: NEUROSCIENCE | ||||||
| 10/30/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.38 | General |
| Category: NEUROSCIENCE | ||||||
| 09/07/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: NEUROSCIENCE | ||||||
| 08/30/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.22 | General |
| Category: NEUROSCIENCE | ||||||
| 08/23/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.25 | General |
| Category: NEUROSCIENCE | ||||||
| 08/14/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.89 | General |
| Category: NEUROSCIENCE | ||||||
| 04/27/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.76 | General |
| Category: NEUROSCIENCE | ||||||
| 04/18/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.67 | General |
| Category: Diabetes | ||||||
| 04/12/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $14.35 | General |
| Category: NEUROSCIENCE | ||||||
| 04/07/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $19.79 | General |
| 03/29/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.22 | General |
| Category: NEUROSCIENCE | ||||||
| 03/06/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.09 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.31 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 4 | 328 | 483 | $39,510 | $20,678 |
| 2020 | 7 | 382 | 517 | $50,625 | $18,819 |
Total Patients
710
Total Services
1,000
Medicare Billing
$39,498
Procedure Codes
11
All Medicare Procedures & Services
11 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 165 | 232 | $21,439 | $11,517 | 53.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 136 | 221 | $13,049 | $7,339 | 56.2% |
| 99496 | Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge | Office | 2021 | 11 | 13 | $3,369 | $1,589 | 47.2% |
| 69210 | Removal of impact ear wax, one ear | Office | 2021 | 16 | 17 | $1,653 | $233.00 | 14.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 159 | 214 | $19,950 | $8,167 | 40.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 120 | 194 | $11,962 | $5,367 | 44.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 29 | 29 | $8,729 | $2,777 | 31.8% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 16 | 16 | $2,000 | $1,046 | 52.3% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 29 | 34 | $6,154 | $969.67 | 15.8% |
| 69210 | Removal of impact ear wax, one ear | Office | 2020 | 18 | 18 | $1,530 | $368.86 | 24.1% |
| 99406 | Smoking and tobacco use intermediate counseling, greater than 3 minutes up to 10 minutes | Office | 2020 | 11 | 12 | $300.00 | $123.75 | 41.3% |
About Daniel Babcock, FNP
Daniel Babcock, FNP is a Family healthcare provider based in Norwich, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/14/2019. The National Provider Identifier (NPI) number assigned to this provider is 1285290460.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Daniel Babcock, FNP has received a total of $797.52 in payments from pharmaceutical and medical device companies, with $149.79 received in 2024. These payments were reported across 45 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($797.52).
As a Medicare-enrolled provider, Babcock has provided services to 710 Medicare beneficiaries, totaling 1,000 services with total Medicare billing of $39,498. Data is available for 2 years (2020–2021), covering 11 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Norwich, NY
- Active Since 05/14/2019
- Last Updated 03/23/2021
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1285290460
Products in Payments
- VRAYLAR (Drug) $419.51
- UBRELVY (Drug) $105.73
- BEXSERO (Biological) $85.55
- XARELTO (Drug) $43.24
- QULIPTA (Drug) $24.56
- Saxenda (Drug) $23.89
- Rybelsus (Drug) $19.67
- PREMARIN (Drug) $15.90
- ZEPBOUND (Drug) $14.47
- ELIQUIS (Drug) $12.80
- SPIRIVA RESPIMAT (Drug) $12.41
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Norwich
Nicole Mckenzie, Msn, Fnp-C, Aprn, MSN, FNP-C, APRN
Family — Payments: $12,075
Family $12,075
Jessica Derochie, Fnp, FNP
Family — Payments: $11,975
Family $11,975
Leonna White, Aprn, Fnp-C, Cfcs,, APRN, FNP-C, CFCS,
Family — Payments: $9,113
Family $9,113
Stacy Marsh, Aprn, APRN
Family — Payments: $8,812
Family $8,812
Samantha Vanvoorhis, Aprn, APRN
Family — Payments: $6,921
Family $6,921
Karolyn Miner, Aprn, APRN
Family — Payments: $5,070
Family $5,070